{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:58:54Z","timestamp":1764251934151,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["CS-113-PP-15","CS-112-PP-03"],"award-info":[{"award-number":["CS-113-PP-15","CS-112-PP-03"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111\\u20132221-E-002-052-MY3","NSTC 113\\u20132320-B-400-024-MY3","NSTC 114\\u20132314-B-400-003"],"award-info":[{"award-number":["NSTC 111\\u20132221-E-002-052-MY3","NSTC 113\\u20132320-B-400-024-MY3","NSTC 114\\u20132314-B-400-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ijbiomac.2025.147362","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:20:04Z","timestamp":1756855204000},"page":"147362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["A self-healing micellar hydrogel system for controlled release of caffeic acid phenethyl ester and durable inhibition of prostate tumor"],"prefix":"10.1016","volume":"327","author":[{"given":"Po-Yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ho","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horng-Dar","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-hui","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Pin","family":"Chuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ijbiomac.2025.147362_bb0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate Cancer A Review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"Jama-J Am Med Assoc"},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0015","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-18-63","article-title":"Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer","volume":"18","author":"Chuu","year":"2011","journal-title":"J. Biomed. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.147362_bb0020","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.147362_bb0025","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","article-title":"Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer","volume":"378","author":"Hussain","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.147362_bb0030","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147362_bb0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.147362_bb0050","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.2018.77.9827","article-title":"Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment","volume":"36","author":"Attard","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147362_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.euo.2023.01.001","article-title":"Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis","volume":"6","author":"Cao","year":"2023","journal-title":"European Urology Oncology"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.147362_bb0060","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaoncol.2024.1549","article-title":"Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer A Systematic Review and Meta-Analysis","volume":"10","author":"El-Taji","year":"2024","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0065","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-024-09807-9","article-title":"Propolis: a natural compound with potential as an adjuvant in cancer therapy - a review of signaling pathways","volume":"51","author":"Valivand","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.147362_bb0070","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2174\/1568026623666230321120631","article-title":"Propolis: Antineoplastic Activity, Constituents, and Mechanisms of Action","volume":"23","author":"Ruiz-Bustos","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147362_bb0075","article-title":"Analysis of the antimicrobial activity of propolis: a narrative review of in-vitro studies","volume":"97","author":"Lazo","year":"2025","journal-title":"An. Acad. Bras. Cienc."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/fcp.12898","article-title":"Advances in the phytochemical screening and biological potential of propolis","volume":"37","author":"de Almeida","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.147362_bb0085","first-page":"4528","article-title":"Inhibition of oxidative stress in HeLa cells by chemopreventive agents","volume":"53","author":"Bhimani","year":"1993","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.147362_bb0090","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1073\/pnas.93.17.9090","article-title":"Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B","volume":"93","author":"Natarajan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1158\/1940-6207.CAPR-12-0004-T","article-title":"Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks","volume":"5","author":"Chuu","year":"2012","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147362_bb0100","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.18632\/oncotarget.3246","article-title":"Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154860","article-title":"Caffeic acid phenethyl ester suppresses EGFR\/FAK\/Akt signaling, migration, and tumor growth of prostate cancer cells","volume":"116","author":"Tseng","year":"2023","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031286","article-title":"Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147362_bb0115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41417-024-00753-z","article-title":"Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT","volume":"31","author":"Kuo","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-019-0404-9","article-title":"Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213","volume":"17","author":"Kuo","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.657","article-title":"Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats","volume":"30","author":"Wang","year":"2009","journal-title":"Biopharm. Drug Dispos."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0130","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/bmc.1702","article-title":"Stability of caffeic acid phenethyl amide (CAPA) in rat plasma","volume":"26","author":"Yang","year":"2012","journal-title":"Biomed. Chromatogr."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.147362_bb0135","article-title":"Novel trends in hydrogel development for biomedical applications: a review","volume":"14","author":"S\u00e1nchez-Cid","year":"2022","journal-title":"Polymers-Basel"},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0140","article-title":"Synthesis and Biomedical Applications of Self-healing Hydrogels","volume":"6","author":"Liu","year":"2018","journal-title":"Front. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41565-022-01085-5","article-title":"A transistor-like pH-sensitive nanodetergent for selective cancer therapy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147362_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202104045","article-title":"Brief outlook on polymeric nanoparticles, micelles, niosomes, hydrogels and liposomes: preparative methods and action","volume":"7","author":"Joy","year":"2022","journal-title":"ChemistrySelect"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001341","article-title":"Recent Advances in Injectable Hydrogels for Controlled and Local Drug Delivery","volume":"10","author":"Rizzo","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0160","article-title":"Biomimetic mineralized DCPA\/ anti-CD47 containing thermo-sensitive injectable hydrogel for bone-metastatic prostate cancer treatment","volume":"31","author":"Tan","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0165","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2147\/IJN.S496746","article-title":"Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA\/CD3 T-Cell Engager for Effective Against Tumors in Mice Model","volume":"20","author":"Wei","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147362_bb0170","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1021\/acs.chemmater.1c00028","article-title":"Injectable Phenolic-Chitosan Self-Healing Hydrogel with Hierarchical Micelle Architectures and Fast Adhesiveness","volume":"33","author":"Lin","year":"2021","journal-title":"Chem. Mater."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.147362_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-5173(95)04386-1","article-title":"Development of amphiphilic diblock copolymers as micellar carriers of taxol","volume":"132","author":"Zhang","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0180","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Investig. Urol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147362_bb0185","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/0008-5472.CAN-04-3992","article-title":"Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice","volume":"65","author":"Chuu","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.1418","article-title":"Systems analysis of EGF receptor signaling dynamics with microwestern arrays","volume":"7","author":"Ciaccio","year":"2010","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nmeth.1418","article-title":"Systems analysis of EGF receptor signaling dynamics with microwestern arrays","volume":"7","author":"Ciaccio","year":"2010","journal-title":"Nat. Methods"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.147362_bb0200","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1073\/pnas.90.21.9901","article-title":"Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression","volume":"90","author":"Higgins","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147362_bb0205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acsmedchemlett.8b00018","article-title":"Strategy for Extending Half-life in Drug Design and Its Significance","volume":"9","author":"Gunaydin","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0210","first-page":"1","article-title":"Advancements in hydrogel design for articular cartilage regeneration: A comprehensive review","volume":"43","author":"Hashemi-Afzal","year":"2025","journal-title":"Bioact Mater"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-019-0169-1","article-title":"The stiffness of living tissues and its implications for tissue engineering","volume":"5","author":"Guimaraes","year":"2020","journal-title":"Nat. Rev. Mater."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.147362_bb0220","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1039\/C9RA10666A","article-title":"A fast UV-curable PU-PAAm hydrogel with mechanical flexibility and self-adhesion for wound healing","volume":"10","author":"Hou","year":"2020","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.147362_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201910748","article-title":"Physical double-network hydrogel adhesives with rapid shape adaptability, fast self-healing, antioxidant and NIR\/pH stimulus-responsiveness for multidrug-resistant bacterial infection and removable wound dressing","volume":"30","author":"Zhao","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117508","article-title":"A plant-inspired long-lasting adhesive bilayer nanocomposite hydrogel based on redox-active Ag\/Tannic acid-Cellulose nanofibers","volume":"255","author":"Chen","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0235","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","article-title":"Pluronic block copolymers for overcoming drug resistance in cancer","volume":"54","author":"Kabanov","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0240","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct Tar"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0245","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pharmthera.2013.10.001","article-title":"MEK in cancer and cancer therapy","volume":"141","author":"Neuzillet","year":"2014","journal-title":"Pharmacol Therapeut"},{"issue":"25","key":"10.1016\/j.ijbiomac.2025.147362_bb0250","doi-asserted-by":"crossref","first-page":"38010","DOI":"10.18632\/oncotarget.9380","article-title":"CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling","volume":"7","author":"Tseng","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020274","article-title":"The Antitumor Effect of Caffeic Acid Phenethyl Ester by Downregulating Mucosa-Associated Lymphoid Tissue 1 via AR\/p53\/NF-kappaB Signaling in Prostate Carcinoma Cells","volume":"14","author":"Chang","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/pat.5874","article-title":"Thermosensitive acetylated carboxymethyl chitosan gel depot systems sustained release caffeic acid phenethyl ester for periodontitis treatment","volume":"34","author":"Peng","year":"2023","journal-title":"Polym. Adv. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147362_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030298","article-title":"Gellan-based hydrogel as a drug delivery system for caffeic acid phenethyl ester in the treatment of oral Candida albicans infections","volume":"16","author":"Garcia","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.147362_bb0270","article-title":"Ros-responsive and scavenging bifunctional hydrogel enables co-delivery of anti-inflammatory agent and osteogenetic nanoparticle for periodontitis treatment","volume":"239","author":"Peng","year":"2024","journal-title":"Mater Design"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.147362_bb0275","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1177\/0091270005281043","article-title":"An evaluation of the pharmacokinetics and pharmacodynamics of the histrelin implant for the palliative treatment of prostate cancer","volume":"45","author":"Dineen","year":"2005","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.147362_bb0280","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-4295(01)01293-6","article-title":"Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin","volume":"58","author":"Schlegel","year":"2001","journal-title":"Urology"},{"issue":"45","key":"10.1016\/j.ijbiomac.2025.147362_bb0285","article-title":"Injectable, Micellar Chitosan Self-Healing Hydrogel for Asynchronous Dual-Drug Delivery to Treat Stroke Rats","volume":"33","author":"Lin","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.147362_bb0290","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1021\/acs.jafc.8b01622","article-title":"Assessment of the antigenotoxic activity of poly(d,l-lactic- co-glycolic acid) nanoparticles loaded with caffeic acid phenethyl ester using the Ames Salmonella\/microsome assay","volume":"66","author":"Arasoglu","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.147362_bb0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.657","article-title":"Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats","volume":"30","author":"Wang","year":"2009","journal-title":"Biopharm. Drug Dispos."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.147362_bb0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10637-009-9334-5","article-title":"Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL\/6 mice","volume":"29","author":"Kudugunti","year":"2011","journal-title":"Investig. New Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.147362_bb0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/bcr782","article-title":"Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?","volume":"6","author":"Miller","year":"2004","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0310","first-page":"479","article-title":"Efficacy and Toxicity of Low-Dose versus Conventional-Dose Chemotherapy for Malignant Tumors: a Meta-Analysis of 6 Randomized Controlled Trials","volume":"18","author":"Xie","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.147362_bb0315","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/annonc\/mdi255","article-title":"Treatment of advanced breast cancer: the good, the bad and the ugly","volume":"16","author":"Colleoni","year":"2005","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.147362_bb0320","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/annonc\/mdj066","article-title":"Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer:: antitumor activity and biological effects","volume":"17","author":"Colleoni","year":"2006","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.147362_bb0325","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.breast.2005.08.026","article-title":"Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy","volume":"14","author":"Munoz","year":"2005","journal-title":"Breast"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302507919X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302507919X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:15:39Z","timestamp":1760501739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302507919X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":65,"alternative-id":["S014181302507919X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147362","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A self-healing micellar hydrogel system for controlled release of caffeic acid phenethyl ester and durable inhibition of prostate tumor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"147362"}}